Cited by 5,850Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Open access

Ridker, Paul M., Hennekens, Charles H., Buring, Julie E., Rifai, Nader·2000·New England Journal of Medicine

DOI 10.1056/nejm200003233421202

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. METHODS: We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and a variety of lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. RESULTS: Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), LDL cholesterol (2.4), apolipoprotein B-100 (3.4), HDL cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P<0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). CONCLUSIONS: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm200003233421202

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citation
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Self-citation
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511

Show all 30 references

Research works printed but not linked: 1

Buring JE, 1992, J Myocard Ischemia, 4, 27

Sorted by citations

Items 501–600 of 1,069

Functional Foods and Nutraceuticals in the Primary Prevention of Cardiovascular Diseases
Alissa, E. M., & Ferns, G. A. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/569486 · Cited by 221
Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein
Mintzer, S., Skidmore, C. T., Abidin, C. J., Morales, M. C., Chervoneva, I., Capuzzi, D. M., & Sperling, M. R. (2009) · Annals of Neurology · doi:10.1002/ana.21615 · Cited by 221
Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals
Park, R., Detrano, R., Xiang, M., Fu, P., Ibrahim, Y. W., LABREE, L. D., & Azen, S. P. (2002) · Circulation · doi:10.1161/01.cir.0000033819.29662.09 · Cited by 220
PPARα in atherosclerosis and inflammation
Zandbergen, F. J., & Plutzky, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.021 · Cited by 219
Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?
Mora, S., & Ridker, P. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.014 · Cited by 219
Self-citation
Mechanisms linking obesity to hypertension
Dorresteijn, J. A. N., Visseren, F. L. J., & Spiering, W. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00914.x · Cited by 218
Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral Therapy
Addy, C., Gavrila, A., Tsiodras, S., Brodovicz, K. G., Karchmer, A. W., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020795 · Cited by 218
Periodontal Disease and Biomarkers Related to Cardiovascular Disease
JOSHIPURA, K. J., Wand, H. C., Merchant, A. T., & Rimm, E. B. (2004) · Journal of Dental Research · doi:10.1177/154405910408300213 · Cited by 217
The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen
Wilson, A., Ryan, M. C., & Boyle, A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.068 · Cited by 217
Full Length Article
Güven, H., Shepherd, R. M., Bach, R. G., Capoccia, B. J., & Link, D. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.101 · Cited by 216
Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage
Hastürk, H., Kantarcı, A., & Dyke, T. E. V. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00118 · Cited by 215
Severity of Periodontal Disease and Number of Remaining Teeth Are Related to the Prevalence of Myocardial Infarction and Hypertension in a Study Based on 4,254 Subjects
Holmlund, A., Holm, G., & Lind, L. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050233 · Cited by 215
Monocyte Count, But Not C-Reactive Protein or Interleukin-6, Is an Independent Risk Marker for Subclinical Carotid Atherosclerosis
Chapman, C., Beilby, J. P., McQuillan, B., Thompson, P. L., & Hung, J. (2004) · Stroke · doi:10.1161/01.str.0000130857.19423.ad · Cited by 215
Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapy
Watson, N. W., Ding, B., Zhu, X., & Frisina, R. D. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.002 · Cited by 215
C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis
Hashimoto, H., Kitagawa, K., Hougaku, H., Shimizu, Y., Sakaguchi, M., Nagai, Y., Iyama, S., Yamanishi, H., Matsumoto, M., & Hori, M. (2001) · Circulation · doi:10.1161/hc2601.091705 · Cited by 215
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina
Zebrack, J. S., Muhlestein, J. B., Horne, B. D., & Anderson, J. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01804-6 · Cited by 215
Quality of Care for Patients With Rheumatoid Arthritis
MacLean, C. H. (2000) · JAMA · doi:10.1001/jama.284.8.984 · Cited by 214
The Effects of Fluticasone with or without Salmeterol on Systemic Biomarkers of Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., Man, S. F. P., Marciniuk, D. D., Ford, G. T., Fitzgerald, M., Wong, E. Y. L., York, E. L., Mainra, R., Ramesh, W., Melenka, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1356oc · Cited by 214
Survival on Dialysis Post–Kidney Transplant Failure: Results From the Scientific Registry of Transplant Recipients
Rao, P. S., Schaubel, D. E., Jia, X., Li, S., Port, F. K., & Saran, R. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.022 · Cited by 213
C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women
Pradhan, A. D., Cook, N. R., Buring, J. E., Manson, J. E., & Ridker, P. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000065636.15310.9c · Cited by 213
Self-citation
Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)
Schillinger, M., Exner, M., Mlekusch, W., Sabeti, S., Amighi, J., Nikowitsch, R., Timmel, E., Kickinger, B., Minar, C., Pones, M., et al. (2005) · Circulation · doi:10.1161/01.cir.0000163569.97918.c0 · Cited by 213
Cardiovascular Complications of Obstructive Sleep Apnea Syndrome: Evidence from Children
Bhattacharjee, R., Gozal, D., Pillar, G., & Gozal, D. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.03.002 · Cited by 212
Do atherosclerosis and type 2 diabetes share a common inflammatory basis?
Pradhan, A. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3052 · Cited by 212
Trans fatty acids – Effects on systemic inflammation and endothelial function
Mozaffarian, D. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.04.007 · Cited by 212
C-reactive protein comes of age
Verma, S., Szmitko, P. E., & Ridker, P. M. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0074 · Cited by 211
Self-citation
YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis
Rathcke, C. N., & Vestergaard, H. (2006) · Inflammation Research · doi:10.1007/s00011-006-0076-y · Cited by 211
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Voulgari, Tentolouris, N., & Papadogiannis, D. E. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11681 · Cited by 211
Multiple Plaque Rupture and C-Reactive Protein in Acute Myocardial Infarction
Tanaka, A., Shimada, K., Sano, T., Namba, M., Sakamoto, T., Nishida, Y., Kawarabayashi, T., Fukuda, D., & Yoshikawa, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.053 · Cited by 211
Mendelian randomization studies in coronary artery disease
Jansen, H., Samani, N. J., & Schunkert, H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu208 · Cited by 211
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease
Nelson, K. A., Fuster, V., & Ridker, P. M. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.05.055 · Cited by 211
Self-citation
Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease
Lowe, G. D. O. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01416.x · Cited by 211
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Gorelick, P. B. (2002) · Stroke · doi:10.1161/hs0302.103657 · Cited by 211
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions
Farrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209
“has been shown to predict cardiovascular events in previously healthy women (33), was significantly higher in women with PCOS and PCO than in controls and this difference could not be attributed to age, BMI, waist-to-hip ratio, and lipid profile (34).”
Background
The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress‐Mediated Diseases
Vítek, L., & Schwertner, H. A. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)43001-8 · Cited by 209
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women
Pannacciulli, N., Cantatore, F. P., Minenna, A., Bellacicco, M., GIORGINO, R., & Pergola, G. D. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801719 · Cited by 209
Epidemiology of coronary heart disease in women
Bello, N. A., & Mosca, L. J. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2003.08.001 · Cited by 208
The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
Rifai, M. A., Silverman, M. G., Nasir, K., Budoff, M. J., Blankstein, R., Szklo, M., Katz, R., Blumenthal, R. S., & Blaha, M. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.011 · Cited by 208
Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis
Okamoto, Y., Folco, E. J. E., Minami, M., Wara, A. K., Feinberg, M. W., Sukhova, G. K., Colvin, R. A., Kihara, S., Funahashi, T., Luster, A. D., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.164988 · Cited by 208
Myocardial Infarction—From Atherosclerosis to Thrombosis
Palasubramaniam, J., Wang, X., & Peter, K. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312578 · Cited by 208
A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women
Blake, G. J., Dada, N., Fox, J. C., Manson, J. E., & Ridker, P. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01554-6 · Cited by 208
Self-citation
Increased platelet activation in patients with stable and acute exacerbation of COPD
Maclay, J. D., McAllister, D., Johnston, S., Raftis, J. B., McGuinnes, C., Deans, A., Newby, D. E., Mills, N. L., & MacNee, W. (2011) · Thorax · doi:10.1136/thx.2010.157529 · Cited by 207
A Prospective Study of Serum C-Reactive Protein and Colorectal Cancer Risk in Men
Gunter, M. J., Stolzenberg‐Solomon, R. Z., Cross, A. J., Leitzmann, M. F., Weinstein, S. J., Wood, R. J., Virtamo, J. R. K., Taylor, P. R., Albanes, D., & Sinha, R. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3631 · Cited by 207
Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient
Stenvinkel, P. (2000) · Blood Purification · doi:10.1159/000014479 · Cited by 207
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Handelman, G. J., Walter, M. F., Adhikarla, R., Gross, J., Dallal, G. E., Levin, N. W., & Blumberg, J. B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051960.x · Cited by 207
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions
Chan, A. W., Bhatt, D. L., Chew, D. P., Reginelli, J. P., Schneider, J. P., Topol, E. J., & Ellis, S. G. (2003) · Circulation · doi:10.1161/01.cir.0000060541.18923.e9 · Cited by 207
C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease
Ridker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206
Self-citation
Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects
Chironi, G. N., Simon, A. C., Hugel, B., Pino, M. D., Gariépy, J., Freyssinet, J., & Tedgui, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000249639.36915.04 · Cited by 206
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis
Montecucco, F., & Mach, F. (2008) · Rheumatology · doi:10.1093/rheumatology/ken395 · Cited by 206
Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis
Zee, R. Y. L., & Ridker, P. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00703-1 · Cited by 206
Self-citation
Cardiorespiratory Fitness and C-Reactive Protein Among a Tri-Ethnic Sample of Women
LaMonte, M. J., Durstine, J. L., Yanowitz, F. G., Lim, T. H., DuBose, K. D., Davis, P. G., & Ainsworth, B. E. (2002) · Circulation · doi:10.1161/01.cir.0000025425.20606.69 · Cited by 206
Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: Evidence from the general population
Spitzer, C., Barnow, S., Völzke, H., Wallaschofski, H., John, U., Freyberger, H. J., Löwe, B., & Grabe, H. J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.06.002 · Cited by 205
Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease
Fredrikson, G. N., Hedblad, B., Berglund, G. L., Alm, R., Ares, M. P. S., Cercek, B., Chyu, K., Shah, P. K., & Nilsson, J. Å. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067935.02679.b0 · Cited by 205
Effects of oxidative stress on endothelial function after a high-fat meal
Tsai, W., Li, Y., Lin, C., Chao, T., & Chen, J.-H. (2004) · Clinical Science · doi:10.1042/cs20030227 · Cited by 204
Effect of COVID-19 on food security, hunger, and food crisis
Kakaei, H., Nourmoradi, H., Bakhtiyari, S., Jalilian, M., & Mirzaei, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91307-2.00005-5 · Cited by 203
Circulating Levels of Oxidative Stress Markers and Endothelial Adhesion Molecules in Men with Abdominal Obesity
Couillard, C., Ruel, G., Archer, W. R., Pomerleau, S., Bergeron, J., Couture, P., Lamarche, B., & Bergeron, N. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2438 · Cited by 202
Metabolic inflammation: Connecting obesity and insulin resistance
Dali‐Youcef, N., Mecili, M., Ricci, R., & Andrès, E. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.705015 · Cited by 201
Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome
Valle, M., Martos, R., Gascón, F., Cañete, R., Zafra, M., & Morales, R. M. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70167-2 · Cited by 201
Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation
Rifai, N., & Ridker, P. M. (2003) · Clinical Chemistry · doi:10.1373/49.4.666 · Cited by 201
Self-citation
Immunomodulatory and anti‐inflammatory effects of chondroitin sulphate
du Souich, P., García, A. G., Vergés, J., & Montell, E. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00826.x · Cited by 200
Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence
Bautista, L. E. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001537 · Cited by 200
Innate immune signals in atherosclerosis
Lundberg, A. M., & Hansson, G. K. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 200
Examining the role of neuroinflammation in major depression
Furtado, M., & Katzman, M. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.009 · Cited by 199
Task force #1—identification of coronary heart disease risk: is there a detection gap?
Pasternak, R. C., Abrams, J., Greenland, P., Smaha, L. A., Wilson, P. W. F., & Miller, N. H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00358-9 · Cited by 199
Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation
Jacob, K., Periago, M. J., Böhm, V., & Ros, G. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507791894 · Cited by 199
Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
Arida, A., Protogerou, A. D., Kitas, G. D., & Sfikakis, P. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071890 · Cited by 199
Interleukin-17 Stimulates C-reactive Protein Expression in Hepatocytes and Smooth Muscle Cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ Activation
Patel, D. N., King, C. A., Bailey, S. R., Holt, J. W., Venkatachalam, K., Agrawal, A. C., Valente, A. J., & Chandrasekar, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703250200 · Cited by 199
C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population
Anand, S. S., Razak, F. A., Yi, Q., Davis, B. C., Jacobs, R., Vuksan, V., Lonn, E., Teo, K. K., McQueen, M., & Yusuf, S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000135845.95890.4e · Cited by 198
IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women
Boekholdt, S. M., Peters, R. J. G., Hack, C. E., Day, N., Luben, R., Bingham, S. A., Wareham, N. J., Reitsma, P. H., & Khaw, K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000134294.54422.2e · Cited by 197
Circulating levels of ICAM‐1, VCAM‐1, and MCP‐1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events
Papagianni, A. A., Alexopoulos, E., Giamalis, P., Gionanlis, L., Belechri, A., Koukoudis, P., & Memmos, D. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.3.435 · Cited by 197
Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Listing, J., Strangfeld, A., Kekow, J., Schneider, M., Kapelle, A., Wassenberg, S., & Zink, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23281 · Cited by 196
Relations of Dietary Magnesium Intake to Biomarkers of Inflammation and Endothelial Dysfunction in an Ethnically Diverse Cohort of Postmenopausal Women
Chacko, S. A., Song, Y., Nathan, L., Tinker, L. F., de Boer, I. H., Tylavsky, F., Wallace, R. B., & Liu, S. (2009) · Diabetes Care · doi:10.2337/dc09-1402 · Cited by 196
Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure
Yin, W., Chen, J., Jen, H.-L., Chiang, M.-C., Huang, W., Feng, A.-N., Young, M. S., & Lin, S. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.11.021 · Cited by 196
An Update on the Role of Markers of Inflammation in Atherosclerosis
Corrado, E., Rizzo, M., Coppola, G., Fattouch, K., Novo, G., Marturana, I., Ferrara, F., & Novo, S. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2600 · Cited by 195
Disease monitoring in inflammatory bowel disease
Chang, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11246 · Cited by 195
Inflammation and Atherosclerosis
Jialal, I., & Devaraj, S. (2001) · Pathology Patterns Reviews · doi:10.1309/j63v-5lth-wyfc-vdr5 · Cited by 195
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome
Basu, A., Du, M., Sanchez, K., Leyva, M. J., Betts, N. M., Blevins, S., Wu, M., Aston, C. E., & Lyons, T. J. (2011) · Nutrition · doi:10.1016/j.nut.2010.01.015 · Cited by 194
Workplace based mindfulness practice and inflammation: A randomized trial
Malarkey, W. B., Jarjoura, D., & Klatt, M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.009 · Cited by 194
Socioeconomic status and stress-induced increases in interleukin-6
Brydon, L., Edwards, S., Mohamed‐Ali, V., & Steptoe, A. (2003) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2003.09.011 · Cited by 194
Immune activation and degradation of tryptophan in coronary heart disease
Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Ērglis, A., Trušinskis, K., & Fuchs, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01186.x · Cited by 194
Subclinical Inflammation and Vascular Dysfunction in Women with Previous Gestational Diabetes Mellitus
Heitritter, S., Solomon, C. G., Mitchell, G. F., Ounis–Skali, N., & Seely, E. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2494 · Cited by 194
A Systematic Review of Epidemiological Associations between Low and Moderate Doses of Ionizing Radiation and Late Cardiovascular Effects, and Their Possible Mechanisms
Little, M. P., Tawn, E. J., Tzoulaki, I., Wakeford, R., Hildebrandt, G., Paris, F., Tapio, S., & Elliott, P. (2007) · Radiation Research · doi:10.1667/rr1070.1 · Cited by 194
Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women
Tanz, L. J., Stuart, J. J., Williams, P. L., Rimm, E. B., Missmer, S. A., Rexrode, K. M., Mukamal, K. J., & Rich-Edwards, J. W. (2017) · Circulation · doi:10.1161/circulationaha.116.025954 · Cited by 194
Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men
Engström, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L., & Lindgärde, F. (2002) · Circulation · doi:10.1161/01.cir.0000017327.69909.ff · Cited by 194
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: The PRIME Study
Luc, G., Arveiler, D., Evans, A., Amouyel, P., Ferrières, J., Bard, J., Elkhalil, L., Fruchart, J., & Ducimetière, P. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00280-6 · Cited by 193
Proposed Cardiovascular Risk Assessment Algorithm Using High-Sensitivity C-Reactive Protein and Lipid Screening
Rifai, N., & Ridker, P. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.1.28 · Cited by 193
Self-citation
Endogenous Reproductive Hormones and C-reactive Protein Across the Menstrual Cycle: The BioCycle Study
Gaskins, A. J., Wilchesky, M., Mumford, S. L., Whitcomb, B. W., Browne, R. W., Wactawski‐Wende, J., Perkins, N. J., & Schisterman, E. F. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr343 · Cited by 193
Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin
McCaffery, J. M., Frasure‐Smith, N., Dubé, M., Théroux, P., Rouleau, G. A., Duan, Q., & Lespérance, F. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000208630.79271.a0 · Cited by 192
Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway
Jia, Z., Nallasamy, P., Liu, D., Shah, H., Li, J. Z., Chitrakar, R., Si, H., McCormick, J., Zhu, H., Wei, Z., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.008 · Cited by 192
Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
Abela, G. S. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.03.003 · Cited by 192
Posttraumatic Stress Disorder and Cardiovascular Disease
Edmondson, D. E., & Cohen, B. E. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.03.004 · Cited by 192
Subclinical Hypothyroidism may be Associated with Elevated High-sensitive C-Reactive Protein (Low Grade Inflammation) and Fasting Hyperinsulinemia
Tuzcu, A., Bahçeci, M., Gökalp, D., Tüzün, Y., & GUNES, K. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.89 · Cited by 192
Blood Donations and Risk of Coronary Heart Disease in Men
Ascherio, A., Rimm, E. B., Giovannucci, E. L., Willett, W. C., & Stampfer, M. J. (2001) · Circulation · doi:10.1161/01.cir.103.1.52 · Cited by 192
Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress
Owen, N., Poulton, T., Hay, F. C., Mohamed‐Ali, V., & Steptoe, A. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00058-8 · Cited by 191
Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis
Schulte, S., Sukhova, G. K., & Libby, P. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070776 · Cited by 191
Update on the Association of Inflammation and Atrial Fibrillation
PATEL, P., DOKAINISH, H., TSAI, P., & LAKKIS, N. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01774.x · Cited by 190
All teas are not created equal
Cheng, T. O. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.05.038 · Cited by 190
Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., Sabatine, M. S., Rifai, N., Giugliano, R. P., DiBattiste, P. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000109491.66226.26 · Cited by 190
Self-citation
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women
Kopp, H., Krzyżanowska, K., Möhlig, M., Spranger, J., Pfeiffer, A. F. H., & Schernthaner, G.-H. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802983 · Cited by 190
Psychosocial Factors in the Development of Heart Disease in Women: Current Research and Future Directions
Low, C. A., Thurston, R. C., & Matthews, K. A. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181f6934f · Cited by 189
Usefulness of high-sensitivity C-Reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction
Zebrack, J. S., Anderson, J. L., Maycock, C. A. A., Horne, B. D., Bair, T. L., & Muhlestein, J. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02190-7 · Cited by 189

Authors: Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N.
Affiliations: Brigham and Women's Hospital (US)
Boston Children's Hospital (US)
ORCID: Ridker, Paul M.
Hennekens, Charles H.
Buring, Julie E.
Rifai, Nader
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-03-23
Volume: 342
Issue: 12
Pages: 836-843
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200003233421202
OpenAlex: W2058610272
Cited by: 5,850
References: 30
Citations by year: 2026: 97 · 2025: 120 · 2024: 113 · 2023: 125 · 2022: 148 · 2021: 143 · 2020: 165 · 2019: 140 · 2018: 167 · 2017: 131 · 2016: 169 · 2015: 199 · 2014: 223 · 2013: 234 · 2012: 258
FWCI: 286.27
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University Libraries (University of Maryland) (submittedVersion)
Digital Repository at the University of Maryland (University of Maryland College Park)
Funders: National Institutes of Health (5r01hl043851-10)
National Heart, Lung, and Blood Institute (R01HL058755, HL43851, HL-58755)
National Cancer Institute (CA-47988, R01CA047988)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: C-reactive protein, inflammatory markers, cardiovascular risk prediction, postmenopausal women, serum amyloid A, interleukin-6, sICAM-1, homocysteine, apolipoprotein B-100, LDL cholesterol, coronary artery disease, myocardial infarction, stroke, coronary revascularization, risk prediction model
MeSH terms: Serum Amyloid A Protein, Analysis of Variance, Apolipoproteins, C-Reactive Protein, Cardiovascular Diseases, Female, Homocysteine, Humans, Lipids, Middle Aged, Prospective Studies, Protein Precursors, Risk, Biomarkers, Interleukin-6, Case-Control Studies, Intercellular Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks